Regardless of tumour stage, <i>LRP1B</i> mutation was significantly correlated with OS in patients undergoing systemic therapy.<h4>Conclusion</h4>Circulating tumour DNA testing demonstrated that TMB is closely associated with OS in patients with HCC. Here, LRP1B is linked to hepatocellular carcinoma.